17beta-hydroxysteroid dehydrogenase inhibitors (Bionetworks)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name17beta-hydroxysteroid dehydrogenase inhibitors (Bionetworks)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action17-hydroxysteroid dehydrogenases inhibitors
Targets17-hydroxysteroid dehydrogenases
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBionetworks GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBionetworks GmbH
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A